PYLARIFY Imaging in High-Risk Prostate Cancer

Videos — February 1, 2022
Steven Rowe, MD, PhD
Radiology and Radiological Science
Johns Hopkins Medicine,
Baltimore, MD
Dr Neal Shore emphasizes the importance of accurate staging of prostate cancer and how PYLARIFY® (piflufolastat F 18) can improve treatment decision-making in patients with prostate cancer.

Related Articles

© Amplity Health. All Rights Reserved. Privacy Policy.